<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

Graduate Program

Research    Alumni    Pharmacy    Clinical Research    Graduate Program

CU Pharmacy Alumnus Strategizes through PhD Program


Recently, we connected with Dr. Chong Kim (CK), who received his PhD in Pharmaceutical Outcomes during the fall 2020 Commencement on Dec. 12. Dr. Kim  describes himself as a critical thinking, highly motivated, and hard working problem solver. Currently, his specific interests lie in optimizing the landscape of the healthcare environment around the world. His main expertise involves observational studies, development of statistical methods, and programming. He's currently working as a manager at Stratevi.

Author Jaron Bryant | Publish Date May 28, 2021
Full Story

School of Pharmacy In the News

NewsMedical

Study highlights importance of positive and negative selection in evolution of SARS-CoV-2 variants

news outletNewsMedical
Publish DateDecember 28, 2021

Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.

Full Story
Health.com

How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts Say

news outletHealth.com
Publish DateDecember 28, 2021

Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.

Full Story
The Guardian

Covid pills are ‘very promising’ – but what are the challenges in using them?

news outletThe Guardian
Publish DateDecember 28, 2021

Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.

Full Story
Vanguard

US, NGO combat cancer, train 34 Nigerian oncology pharmacists

news outletVanguard
Publish DateDecember 14, 2021

Cindy O’Bryant, PharmD, had her recent Fulbright-sponsored work in Nigeria featured in a Vanguard article. The story examines the work being done to help reduce the high incidence of cancer, tackle late detection and improve general outlook of cancer in Nigeria.

Full Story